Authors: Tubiana-Hulin, M Beuzeboc, P Mauriac, L Barbet, N Frenay, M Monnier, A Pion, JM Switsers, O Misset, JL Assadourian, S Bessa, E

Citation: M. Tubiana-hulin et al., Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases, B CANCER, 88(7), 2001, pp. 701-707

Authors: Gerard, JP Chapet, O Romestaing, P Favrel, V Barbet, N Mornex, F

Citation: Jp. Gerard et al., Local excision and adjuvant radiotherapy for rectal adenocarcinoma Tl-2N0, GASTRO CL B, 24(4), 2000, pp. 430-435

Authors: Schroder, FH Kranse, R Barbet, N Hop, WCJ Kandra, A Lassus, M

Citation: Fh. Schroder et al., Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?, PROSTATE, 42(2), 2000, pp. 107-115

Authors: Zhou, HH Choi, L Lau, H Bruntsch, U De Vries, EEGE Eckhardt, G Van Oosterom, AT Verweij, J Schran, H Barbet, N Linnartz, R Capdeville, R

Citation: Hh. Zhou et al., Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486Ain phase I studies in patients with advanced cancers, J CLIN PHAR, 40(3), 2000, pp. 275-283

Authors: Paridaens, R Uges, DRA Barbet, N Choi, L Seeghers, M van der Graaf, WTA Groen, HJM Dumez, H Van Buuren, I Muskiet, F Capdeville, R van Oosterom, AT de Vries, EGE

Citation: R. Paridaens et al., A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours, BR J CANC, 83(5), 2000, pp. 594-601